The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.

Cannabis Consensus Costs and Cost Analysis Humans Self Report
assessment cannabis dose iCanntoolkit measurement standardisation

Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
06 2022
Historique:
revised: 03 09 2021
received: 09 04 2021
accepted: 07 09 2021
pubmed: 1 10 2021
medline: 10 5 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. A group of 25 international expert cannabis researchers convened to discuss a multidisciplinary framework for minimum standards to measure cannabis use globally in diverse settings. The expert-based consensus agreed upon a three-layered hierarchical framework. Each layer-universal measures, detailed self-report and biological measures-reflected different research priorities and minimum standards, costs and ease of implementation. Additional work is needed to develop valid and precise assessments. Consistent use of the proposed framework across research, public health, clinical practice and medical settings would facilitate harmonisation of international evidence on cannabis consumption, related harms and approaches to their mitigation.

Sections du résumé

BACKGROUND
The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use.
METHODS
A group of 25 international expert cannabis researchers convened to discuss a multidisciplinary framework for minimum standards to measure cannabis use globally in diverse settings.
RESULTS
The expert-based consensus agreed upon a three-layered hierarchical framework. Each layer-universal measures, detailed self-report and biological measures-reflected different research priorities and minimum standards, costs and ease of implementation. Additional work is needed to develop valid and precise assessments.
CONCLUSIONS
Consistent use of the proposed framework across research, public health, clinical practice and medical settings would facilitate harmonisation of international evidence on cannabis consumption, related harms and approaches to their mitigation.

Identifiants

DOI: 10.1111/add.15702 PMID: 34590359 PMC: PMC9298052
pubmed: 34590359
doi: 10.1111/add.15702
pmc: PMC9298052
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1510-1517

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Addict Behav. 2012 Mar;37(3):225-33
pubmed: 22143002
Addiction. 2014 Jul;109(7):1101-9
pubmed: 24628797
Lancet Psychiatry. 2015 Mar;2(3):233-8
pubmed: 26359901
Addiction. 2022 Jun;117(6):1510-1517
pubmed: 34590359
J Anal Toxicol. 2008 Oct;32(8):562-9
pubmed: 19007504
Psychol Med. 2019 Jul;49(9):1574-1580
pubmed: 30176957
World Psychiatry. 2020 Jun;19(2):189-191
pubmed: 32394580
Neuropsychology. 2016 May;30(4):405-15
pubmed: 26986749
Front Psychiatry. 2020 Dec 03;11:598150
pubmed: 33343424
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Curr Pharm Des. 2014;20(13):2138-67
pubmed: 23829361
Addiction. 2017 Dec;112(12):2167-2177
pubmed: 28556310
Addiction. 2021 May;116(5):1000-1010
pubmed: 33160291
Drug Alcohol Depend. 2019 Dec 1;205:107621
pubmed: 31698323
Addiction. 2020 Jun;115(6):1182-1186
pubmed: 31944463
Addiction. 2011 Feb;106(2):238-44
pubmed: 21208311
Adicciones. 2017 Sep 29;29(4):227-232
pubmed: 27749977
Addiction. 2014 Oct;109(10):1686-94
pubmed: 24894801
Cannabis Cannabinoid Res. 2022 Jun;7(3):345-354
pubmed: 33998866
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Addiction. 2020 Jul;115(7):1207-1216
pubmed: 31606008
Front Psychiatry. 2016 Jul 05;7:104
pubmed: 27458388
Drug Alcohol Depend. 2006 Nov 8;85(2):114-22
pubmed: 16723194
J Stud Alcohol. 1995 Jul;56(4):423-32
pubmed: 7674678
Psychopathology. 2006;39(4):175-8
pubmed: 16636640
Biol Psychiatry. 2016 Apr 1;79(7):e17-31
pubmed: 26858212
Drug Alcohol Depend. 2020 Jul 1;212:107993
pubmed: 32360455
JAMA Psychiatry. 2020 Oct 1;77(10):1044-1051
pubmed: 32459328
J Abnorm Psychol. 2003 Aug;112(3):393-402
pubmed: 12943018
JAMA Psychiatry. 2016 Sep 1;73(9):995-6
pubmed: 27463333
J Addict Med. 2011 Mar;5(1):1-8
pubmed: 21321675
Drug Alcohol Depend. 2017 Jul 1;176:109-116
pubmed: 28531767
Psychol Med. 2015 Nov;45(15):3181-9
pubmed: 26213314
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):60-67
pubmed: 26858993

Auteurs

Valentina Lorenzetti (V)

Neuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
ORCID: 0000-0002-5917-7068

Chandni Hindocha (C)

Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
ORCID: 0000-0003-1692-7401

Kat Petrilli (K)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.

Paul Griffiths (P)

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
ORCID: 0000-0003-2844-3391

Jamie Brown (J)

Behavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.
ORCID: 0000-0002-2797-5428

Álvaro Castillo-Carniglia (Á)

Society and Health Research Center and School of Public Health, Universidad Mayor, Santiago, Chile.
Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
ORCID: 0000-0002-3016-890X

Jonathan P Caulkins (JP)

Carnegie Mellon University Heinz College, Pittsburgh, PA, USA.
ORCID: 0000-0002-7748-9989

Amir Englund (A)

Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ORCID: 0000-0002-2478-209X

Mahmoud A ElSohly (MA)

National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA.
Department Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS, USA.
ORCID: 0000-0002-0019-2001

Suzanne H Gage (SH)

Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
ORCID: 0000-0002-2368-1115

Teodora Groshkova (T)

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.

Antoni Gual (A)

Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, RTA, Barcelona, Spain.
ORCID: 0000-0002-7130-981X

David Hammond (D)

School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.
ORCID: 0000-0001-8197-6010

Will Lawn (W)

Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK.
ORCID: 0000-0002-0143-2724

Hugo López-Pelayo (H)

Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, RTA, Barcelona, Spain.
ORCID: 0000-0002-3850-8374

Jakob Manthey (J)

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
ORCID: 0000-0003-1231-3760

Claire Mokrysz (C)

Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
ORCID: 0000-0002-1970-8530

Rosalie Liccardo Pacula (RL)

USC Sol Price School of Public Policy, USC Leonard D. Schaeffer Center for Health Policy & Economics, Los Angeles, CA, USA.
ORCID: 0000-0002-6145-9865

Margriet van Laar (M)

Trimbos Institute, Utrecht, The Netherlands.
ORCID: 0000-0003-3977-126X

Ryan Vandrey (R)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
ORCID: 0000-0001-6657-884X

Elle Wadsworth (E)

School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.
ORCID: 0000-0003-0797-8493

Adam Winstock (A)

Behavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.
Global Drug Survey, London, UK.

Wayne Hall (W)

National Addiction Centre, King's College London, London, UK.
National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Australia.
ORCID: 0000-0003-1984-0096

H Valerie Curran (HV)

Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
ORCID: 0000-0001-6011-6978

Tom P Freeman (TP)

Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
ORCID: 0000-0002-5667-507X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Rosanae › Rosales › Cannabaceae › Cannabis › The International Cannabis Toolkit...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › The International Cannabis Toolkit...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › The International Cannabis Toolkit...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The International Cannabis Toolkit...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Autorapport › The International Cannabis Toolkit...